{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T22:57:24Z","timestamp":1754261844322},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.yebeh.2011.08.018","type":"journal-article","created":{"date-parts":[[2011,9,26]],"date-time":"2011-09-26T15:23:11Z","timestamp":1317050591000},"page":"606-609","source":"Crossref","is-referenced-by-count":2,"title":["Off-label gabapentin masking ictal triphasic waves: Case analysis of neuropsychiatric and electrographic correlates"],"prefix":"10.1016","volume":"22","author":[{"given":"Kenneth R.","family":"Kaufman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Struck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2011.08.018_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yebeh.2011.03.011","article-title":"Antiepileptic drugs in the treatment of psychiatric disorders","volume":"21","author":"Kaufman","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2011.08.018_bb0010","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/pds.1051","article-title":"An epidemiological investigation of off-label anticonvulsant use in the Georgia Medicaid population","volume":"14","author":"Chen","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.yebeh.2011.08.018_bb0015","first-page":"e197","article-title":"Anticonvulsant use after formulary status change for brand-name second-generation anticonvulsants","volume":"16","author":"Patel","year":"2010","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.yebeh.2011.08.018_bb0020","doi-asserted-by":"crossref","first-page":"559","DOI":"10.18553\/jmcp.2003.9.6.559","article-title":"Examination of the evidence for off-label use of gabapentin","volume":"9","author":"Mack","year":"2003","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.yebeh.2011.08.018_bb0025","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1528-1167.2010.02782.x","article-title":"Video-EEG monitoring: safety and adverse events in 507 consecutive patients","volume":"52","author":"Dobesberger","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2011.08.018_bb0030","doi-asserted-by":"crossref","first-page":"266","DOI":"10.18553\/jmcp.2002.8.4.266","article-title":"Gabapentin use in a managed Medicaid population","volume":"8","author":"Hamer","year":"2002","journal-title":"J Manag Care Pharm"},{"issue":"5 Suppl","key":"10.1016\/j.yebeh.2011.08.018_bb0035","first-page":"1","article-title":"Practice guideline for the treatment of patients with delirium","volume":"156","author":"American Psychiatric Association","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.yebeh.2011.08.018_bb0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/1086508X.2011.11079796","article-title":"Triphasic waves","volume":"51","author":"Brigo","year":"2011","journal-title":"Am J Electroneurodiagnostic Technol"},{"key":"10.1016\/j.yebeh.2011.08.018_bb0045","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.yebeh.2007.07.014","article-title":"Significance of atypical triphasic waves for diagnosing nonconvulsive status epilepticus","volume":"11","author":"Kaya","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2011.08.018_bb0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.yebeh.2011.03.028","article-title":"Frontal lobe nonconvulsive status epilepticus: a case of epileptic stuttering, aphemia, and aphasia\u2014not a sign of psychogenic nonepileptic seizures","volume":"21","author":"Kaplan","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2011.08.018_bb0055","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nrneurol.2011.24","article-title":"Differentiating between nonepileptic and epileptic seizures","volume":"7","author":"Devinsky","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.yebeh.2011.08.018_bb0060","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.yebeh.2010.05.020","article-title":"MELAS with recurrent complex partial seizures, nonconvulsive status epilepticus, psychosis, and behavioral disturbances: case analysis with literature review","volume":"18","author":"Kaufman","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2011.08.018_bb0065","doi-asserted-by":"crossref","DOI":"10.1111\/j.1528-1167.2011.03168.x","article-title":"Risk and prognostic factor of status epilepticus in the elderly: a case-controlled study","author":"Canoui-Poitrine","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2011.08.018_bb0070","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1528-1167.2007.01033.x","article-title":"Nonconvulsive status epilepticus in the elderly: a case-controlled study","volume":"48","author":"Bottaro","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2011.08.018_bb0075","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1212\/01.WNL.0000082653.40257.0B","article-title":"Assessment of acute morbidity and mortality in nonconvulsive status epilepticus","volume":"61","author":"Shneker","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2011.08.018_bb0080","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1001\/archneur.63.12.1746","article-title":"Clinical implications of status epilepticus in patients with neoplasm","volume":"63","author":"Cavaliere","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2011.08.018_bb0085","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2125.2011.03991.x","article-title":"Neurotoxic effects associated with antibiotic use: management considersation","volume":"72","author":"Grill","year":"2011","journal-title":"Br J Clin Pharmacol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505011004823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505011004823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T19:29:51Z","timestamp":1638905391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505011004823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1525505011004823"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2011.08.018","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}